SK Biopharmaceuticals Co., Ltd.
326030Biotechnology
₩77,800.00+3.46%As of Oct 29vs prior close
- Market cap
- $4.6B
- P/E (TTM)
- 15.2×
- P/E (FY1)
- 18.4×
- From 52W high
- −44.71%
- EPS (LTM)
- ₩5,119.90
- Revenue (LTM)
- ₩861.3B
- Net margin
- 46.55%
Nomior Score
48
Anchored CompounderBottom 45% of the scored universe
Growth68
Quality67
Value50
Momentum11
Resilience52
Growth
+42.12%revenue a year over 3 fiscal years
YE22 ₩246.2BLTM ₩861.3B
Connections
Revenue to profitYE25
38% of revenue became net profit, down 6 pts on a year.